These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33121976)

  • 1. Down-regulation of lncRNA PCGEM1 inhibits cervical carcinoma by modulating the miR-642a-5p/LGMN axis.
    Liu Y; Wang Y; Shen X; Chen C; Ni H; Sheng N; Hua M; Wu Y
    Exp Mol Pathol; 2020 Dec; 117():104561. PubMed ID: 33121976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis.
    Liu Y; Liu Y; Wang Y; Wang Q; Yan Y; Zhang D; Liu H
    Oncol Res; 2024; 32(7):1221-1229. PubMed ID: 38948025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PCGEM1 enhances metastasis and gastric cancer invasion through targeting of miR-129-5p to regulate P4HA2 expression.
    Zhang T; Piao HY; Guo S; Zhao Y; Wang Y; Zheng ZC; Zhang J
    Exp Mol Pathol; 2020 Oct; 116():104487. PubMed ID: 32622013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro.
    Chen J; Yuan D; Hao Q; Zhu D; Chen Z
    Adv Clin Exp Med; 2021 Aug; 30(8):831-838. PubMed ID: 34286514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
    Guo M; Lin B; Li G; Lin J; Jiang X
    J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma.
    Li Q; Shen F; Zhao L
    Biomed Pharmacother; 2018 Nov; 107():918-928. PubMed ID: 30257404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA PCGEM1 Regulates the Progress of Colorectal Cancer through Targeting miR-129-5p/SOX4.
    Guan B; Chen F; Wu Z; Wang C; Yang J
    Dis Markers; 2022; 2022():2876170. PubMed ID: 36193492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA PCGsEM1 Contributes to the Proliferation, Migration and Invasion of Non-small Cell Lung Cancer Cells via acting as a Sponge for miR-152-3p.
    Huang J; Lou J; Liu X; Xie Y
    Curr Pharm Des; 2021; 27(46):4663-4670. PubMed ID: 34455968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
    Zhang J; Zhou M; Zhao X; Wang G; Li J
    Pathol Res Pract; 2020 Aug; 216(8):152994. PubMed ID: 32402537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
    Dai SG; Guo LL; Xia X; Pan Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):486-495. PubMed ID: 30720155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer.
    Guo H; Yang S; Li S; Yan M; Li L; Zhang H
    Biomed Pharmacother; 2018 Jun; 102():749-757. PubMed ID: 29604594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L; Qiu K; Gao W; Shi C; Shu F
    BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
    Tao M; Zhou Y; Jin Y; Pu J
    Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA NR2F1-AS1 Inhibits the Malignant Properties of Cervical Cancer Cells via Targeting miR-642a-3p/NR2F1 Axis.
    Zhang L; Zhang Y; Zhou J; Wang Y; Wang H; Huang M; Yu Q; Qi S
    Rev Invest Clin; 2022; 74(4):181-192. PubMed ID: 36087939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis.
    Gao Y; Zou T; Liang W; Zhang Z; Qie M
    Cancer Gene Ther; 2021 Jun; 28(6):619-633. PubMed ID: 33139818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
    Wang Q; Ding J; Nan G; Lyu Y; Ni G
    J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis.
    Hu Y; Ma Y; Liu J; Cai Y; Zhang M; Fang X
    BMC Cancer; 2019 Nov; 19(1):1157. PubMed ID: 31779593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on the role of PCGEM1 lncRNA in cancer.
    Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
    Pathol Res Pract; 2022 Dec; 240():154223. PubMed ID: 36403313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.